Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Robey, Pamela G  [Clear All Filters]
Journal Article
Raimondo D, Remoli C, Astrologo L, Burla R, La Torre M, Vernì F, Tagliafico E, Corsi A, Del Giudice S, Persichetti A, et al. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone. PLoS One. 2020;15(1):e0227279.
Gadomski S, Fielding C, García-García A, Korn C, Kapeni C, Ashraf S, Villadiego J, Del Toro R, Domingues O, Skepper JN, et al. A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise. Cell Stem Cell. 2022.
Saggio I, Remoli C, Spica E, Cersosimo S, Sacchetti B, Robey PG, Holmbeck K, Cumano A, Boyde A, Bianco P, et al. Constitutive Expression of Gsα(R201C) in Mice Produces a Heritable, Direct Replica of Human Fibrous Dysplasia Bone Pathology and Demonstrates Its Natural History. J Bone Miner Res. 2014.
Featherall J, Robey PG, Rowe DW. Continuing Challenges in Advancing Preclinical Science in Skeletal Cell-Based Therapies and Tissue Regeneration. J Bone Miner Res. 2018.
Phillips MD, Kuznetsov SA, Cherman N, Park K, Chen KG, McClendon BN, Hamilton RS, McKay RDG, Chenoweth JG, Mallon BS, et al. Directed Differentiation of Human Induced Pluripotent Stem Cells Toward Bone and Cartilage: In Vitro Versus In Vivo Assays. Stem Cells Transl Med. 2014.
Nemeth K, Wilson TM, Ren JJ, Sabatino M, Stroncek DM, Krepuska M, Bai Y, Robey PG, Metcalfe DD, Mezey E. Impaired function of bone marrow stromal cells in systemic mastocytosis. Stem Cell Res. 2015;15(1):42-53.
Kidwai FK, Canalis E, Robey PG. Induced pluripotent stem cell technology in bone biology. Bone. 2023:116760.
Franco RAnn G, McKenna E, Robey PG, Shajib MShaffiulah, Crawford RW, Doran MR, Futrega K. Inhibition of BMP signaling with LDN 193189 can influence bone marrow stromal cell fate but does not prevent hypertrophy during chondrogenesis. Stem Cell Reports. 2022.
Chen KG, Park K, Maric D, Johnson KR, Robey PG, Mallon BS. Metabolic Quadrivalency in RSeT Human Embryonic Stem Cells. bioRxiv. 2024.
Breunig M, Merkle J, Wagner M, Melzer MK, Barth TFE, Engleitner T, Krumm J, Wiedenmann S, Cohrs CM, Perkhofer L, et al. Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells. Cell Stem Cell. 2021.
Sacchetti B, Funari A, Remoli C, Giannicola G, Kögler G, Liedtke S, Cossu G, Serafini M, Sampaolesi M, Tagliafico E, et al. No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels. Stem Cell Reports. 2016;6(6):897-913.
Chen KG, Johnson KJ, Park K, Maric D, Yang F, Liu WFang, Fann YC, Mallon BS, Robey PG. Resistance to Naive and Formative Pluripotency Conversion in RSeT Human Embryonic Stem Cells. bioRxiv. 2024.
Tamaoki N, Siebert S, Maeda T, Ha N-H, Good ML, Huang Y, Vodnala SK, Haro-Mora JJ, Uchida N, Tisdale JF, et al. Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells. Cell Rep Methods. 2023;3(4):100460.
Chen RJ, Zhang G, Garfield SH, Shi Y-J, Chen KG, Robey PG, Leapman RD. Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States. PLoS One. 2015;10(11):e0142554.